07:10 AM EDT, 10/21/2025 (MT Newswires) -- Quest Diagnostics ( DGX ) reported Q3 adjusted earnings Tuesday of $2.60 per diluted share, up from $2.30 a year earlier.

Analysts polled by FactSet expected $2.50.

Revenue for the quarter ended Sept. 30 was $2.82 billion, up from $2.49 billion a year earlier.

Analysts surveyed by FactSet expected $2.74 billion.

For 2025, the company now expects adjusted EPS of $9.76 to $9.84 on revenue of $10.96 billion to $11 billion. Analysts polled by FactSet expect non-GAAP EPS of $9.75 on revenue of $10.87 billion..

Quest Diagnostics ( DGX ) previously expected adjusted EPS of $9.63 to $9.83 on revenue of $10.80 billion to $10.92 billion.

The company's shares were up 4.5% in recent premarket activity.